title: Aminoglycoside-hybrid ligands targeting the ribosomal decoding site.
authors.affiliation: Department of Medicinal Chemistry, Anadys Pharmaceuticals, Inc. 3115 Merryfield Row, San Diego, CA 92121, USA. dvourloumis@anadyspharma.com
authors.forename: Dionisios
authors.initials: D
authors.lastname: Vourloumis
authors.forename: Geoffrey C
authors.initials: GC
authors.lastname: Winters
authors.forename: Klaus B
authors.initials: KB
authors.lastname: Simonsen
authors.forename: Masayuki
authors.initials: M
authors.lastname: Takahashi
authors.forename: Benjamin K
authors.initials: BK
authors.lastname: Ayida
authors.forename: Sarah
authors.initials: S
authors.lastname: Shandrick
authors.forename: Qiang
authors.initials: Q
authors.lastname: Zhao
authors.forename: Qing
authors.initials: Q
authors.lastname: Han
authors.forename: Thomas
authors.initials: T
authors.lastname: Hermann
mesh_terms: D000617:Aminoglycosides / Q000737:chemistry / Q000494:pharmacology*; D001483:Base Sequence; D001665:Binding Sites; D008024:Ligands; D008969:Molecular Sequence Data; D009154:Mutation; D014176:Protein Biosynthesis / Q000187:drug effects; D017433:Protein Structure, Secondary; D012335:RNA, Ribosomal / Q000187:drug effects*
chemical_list: D000617:Aminoglycosides; D008024:Ligands; D012335:RNA, Ribosomal